Regulus Therapeutics Inc. (RGLS) NASDAQ

$0.36 -0.03 (-6.55%)

Market Cap: $33.73M

As of 12/01/21 04:00 PM EST. Market closed.

(RGLS)

Regulus Therapeutics Inc. (RGLS) NASDAQ

$0.36 -0.03 (-6.55%)

Market Cap: $33.73M

As of 12/01/21 04:00 PM EST. Market closed.

Regulus Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in La Jolla, ... read more

Regulus Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in La Jolla, CA. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joseph Hagan
Full Time Employees
24
CEO Compensation (Base)
$475,300
CEO Compensation (Total)
$1.92M
URL
Address
10628 Science Center Dr Ste 225, California, San Diego, 92121-1124.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joseph Hagan
Full Time Employees
24
CEO Compensation (Base)
$475,300
CEO Compensation (Total)
$1.92M
Address
10628 Science Center Dr Ste 225, California, San Diego, 92121-1124.
KEY STATS
Open
$0.37
Previous Close
$0.39
Days Range
$0.36 - $0.39
52 week range
$0.34 - $2.32
Volume
1,686,790
Avg. Volume (30 days)
1,697,965
Market Cap
$33.73M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
87,047,832
Open
$0.37
Previous Close
$0.39
Days Range
$0.36 - $0.39
52 week range
$0.34 - $2.32
Volume
1,686,790
Avg. Volume (30 days)
1,697,965
Market Cap
$33.73M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
87,047,832

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR REGULUS THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
PAPADOPOULOS STELIOS Director Nov 30, 2021 Option Exercise $0.36 2,222,222 800,000 5,061,929 Dec 01, 2021, 04:12 PM
Aker Christopher Ray Sr. VP & General Counsel May 17, 2021 Sale $0.89 860 765 41,754 May 17, 2021, 07:12 PM
Hagan Joseph P President and CEO Feb 16, 2021 Sale $1.72 4,144 7,128 244,628 Apr 16, 2021, 04:11 PM
Aker Christopher Ray Sr. VP & General Counsel Feb 16, 2021 Sale $1.72 828 1,424 42,614 Feb 17, 2021, 05:23 PM
Hagan Joseph P President and CEO Feb 16, 2021 Sale $1.72 4,144 7,128 485,756 Feb 17, 2021, 05:23 PM
PAPADOPOULOS STELIOS Director Dec 04, 2020 Option Exercise $0.63 793,528 500,002 2,839,707 Jan 27, 2021, 08:16 PM
Walker Paul Edward 10% Owner Dec 04, 2020 Buy $0.62 4,398,602 2,735,930 6,451,056 Dec 07, 2020, 05:14 PM
Sonsini Peter W. 10% Owner Dec 04, 2020 Buy $0.62 4,398,602 2,735,930 6,451,056 Dec 07, 2020, 05:13 PM
SANDELL SCOTT D 10% Owner Dec 04, 2020 Buy $0.62 4,398,602 2,735,930 6,451,056 Dec 07, 2020, 05:12 PM
MAKOWER JOSHUA 10% Owner Dec 04, 2020 Buy $0.62 4,398,602 2,735,930 6,451,056 Dec 07, 2020, 05:12 PM
Makhzoumi Mohamad 10% Owner Dec 04, 2020 Buy $0.62 4,398,602 2,735,930 6,451,056 Dec 07, 2020, 05:11 PM
Florence Anthony A. Jr. 10% Owner Dec 04, 2020 Buy $0.62 4,398,602 2,735,930 6,451,056 Dec 07, 2020, 05:10 PM
Chang Carmen 10% Owner Dec 04, 2020 Buy $0.62 4,398,602 2,735,930 6,451,056 Dec 07, 2020, 05:10 PM
Behbahani Ali 10% Owner Dec 04, 2020 Buy $0.62 4,398,602 2,735,930 6,451,056 Dec 07, 2020, 05:09 PM
BASKETT FOREST 10% Owner Dec 04, 2020 Buy $0.62 4,398,602 2,735,930 6,451,056 Dec 07, 2020, 05:08 PM
Growth Equity Opportunities V, LLC 10% Owner Dec 04, 2020 Buy $0.62 4,398,602 2,735,930 6,451,056 Dec 07, 2020, 05:06 PM
Hagan Joseph P President and CEO Dec 04, 2020 Option Exercise $0.63 39,680 25,002 225,674 Dec 07, 2020, 04:22 PM
PAPADOPOULOS STELIOS Director Dec 04, 2020 Option Exercise $0.63 793,528 500,002 1,986,729 Dec 07, 2020, 04:21 PM
Aker Christopher Ray Sr. VP & General Counsel Nov 16, 2020 Sale $0.52 876 456 25,762 Nov 18, 2020, 04:10 PM
Hagan Joseph P President and CEO Nov 16, 2020 Sale $0.52 6,094 3,176 215,994 Nov 18, 2020, 04:09 PM
Hagan Joseph P President and CEO Aug 14, 2020 Sale $0.60 4,245 2,568 222,088 Aug 17, 2020, 08:22 PM
Aker Christopher Ray Sr. VP & General Counsel Aug 14, 2020 Sale $0.61 872 528 26,638 Aug 17, 2020, 08:21 PM
Hagan Joseph P President and CEO May 15, 2020 Sale $0.63 4,426 2,774 226,333 May 18, 2020, 04:28 PM
Aker Christopher Ray Sr. VP & General Counsel May 15, 2020 Sale $0.63 909 570 27,510 May 18, 2020, 04:27 PM
Hagan Joseph P President and CEO Feb 18, 2020 Sale $0.83 4,324 3,591 230,759 Feb 19, 2020, 06:09 PM
Aker Christopher Ray Sr. VP & General Counsel Feb 18, 2020 Sale $0.83 888 737 28,419 Feb 19, 2020, 06:08 PM
Hagan Joseph P President and CEO Jan 02, 2020 Sale $0.97 8,345 8,067 235,083 Jan 03, 2020, 04:07 PM
Aker Christopher Ray Sr. VP & General Counsel Jan 02, 2020 Sale $0.97 2,239 2,164 29,307 Jan 03, 2020, 04:06 PM
Aker Christopher Ray Sr. VP & General Counsel Nov 14, 2019 Sale $0.64 833 533 31,546 Nov 15, 2019, 05:37 PM
Hagan Joseph P President and CEO Nov 14, 2019 Sale $0.64 5,838 3,736 243,428 Nov 15, 2019, 05:36 PM
Aker Christopher Ray Sr. VP & General Counsel Oct 01, 2019 Sale $0.68 2,346 1,602 32,379 Oct 02, 2019, 06:50 PM
Hagan Joseph P President and CEO Oct 01, 2019 Sale $0.68 8,743 5,969 249,266 Oct 02, 2019, 06:17 PM
Hagan Joseph P President and CEO Aug 15, 2019 Sale $0.55 4,375 2,409 258,009 Aug 16, 2019, 04:17 PM
Aker Christopher Ray Sr. VP & General Counsel Aug 15, 2019 Sale $0.55 899 495 34,725 Aug 16, 2019, 04:16 PM
Hagan Joseph P President and CEO Jul 01, 2019 Sale $1.31 5,783 7,584 262,384 Jul 02, 2019, 05:42 PM
Aker Christopher Ray Sr. VP & General Counsel Jul 01, 2019 Sale $1.31 2,225 2,918 35,624 Jul 02, 2019, 05:42 PM
Chevallard Daniel R. Chief Financial Officer Jul 01, 2019 Sale $1.31 2,669 3,500 77,870 Jul 02, 2019, 05:41 PM
PAPADOPOULOS STELIOS Director May 07, 2019 Option Exercise $1.08 370,370 400,000 1,189,872 May 21, 2019, 04:46 PM
RASTETTER WILLIAM H Director May 07, 2019 Option Exercise $1.08 92,889 100,320 154,223 May 21, 2019, 04:45 PM
Witz Pascale Director May 07, 2019 Option Exercise $1.08 29,630 32,000 37,849 May 21, 2019, 04:44 PM
Hagan Joseph P President and CEO May 07, 2019 Option Exercise $1.08 33,194 35,850 64,542 May 21, 2019, 04:42 PM
Hagan Joseph P President and CEO May 16, 2019 Sale $1.22 39,352 47,966 268,167 May 16, 2019, 05:25 PM
Chevallard Daniel R. Chief Financial Officer May 15, 2019 Sale $1.41 10,000 14,089 80,539 May 16, 2019, 05:21 PM
Aker Christopher Ray Sr. VP & General Counsel May 15, 2019 Sale $1.41 6,950 9,796 59,309 May 16, 2019, 05:21 PM
Walker Paul Edward 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 10, 2019, 10:59 AM
Walker Paul Edward Director May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:08 PM
Sonsini Peter W. 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:07 PM
SANDELL SCOTT D 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:07 PM
MOTT DAVID M 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:06 PM
MAKOWER JOSHUA 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:06 PM
Makhzoumi Mohamad 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:05 PM
Florence Anthony A. Jr. 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:05 PM
Chang Carmen 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:05 PM
Behbahani Ali 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:04 PM
BASKETT FOREST 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:04 PM
BARRIS PETER J 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:02 PM
Growth Equity Opportunities V, LLC 10% Owner May 07, 2019 Buy $1.08 1,136,704 1,227,640 2,052,454 May 09, 2019, 06:02 PM
Hagan Joseph P President and CEO May 07, 2019 Buy $1.08 33,194 35,850 64,542 May 08, 2019, 05:15 PM
Witz Pascale Director May 07, 2019 Buy $1.08 29,630 32,000 37,849 May 08, 2019, 05:15 PM
RASTETTER WILLIAM H Director May 07, 2019 Buy $1.08 92,889 100,320 154,223 May 08, 2019, 05:14 PM
PAPADOPOULOS STELIOS Director May 07, 2019 Buy $1.08 370,370 400,000 1,189,872 May 08, 2019, 05:13 PM
Hagan Joseph P President and CEO Apr 01, 2019 Sale $0.98 5,842 5,731 31,348 Apr 03, 2019, 04:31 PM
Aker Christopher Ray Sr. VP & General Counsel Apr 01, 2019 Sale $0.98 2,710 2,659 6,287 Apr 03, 2019, 04:15 PM
Chevallard Daniel R. Chief Financial Officer Apr 01, 2019 Sale $0.98 3,253 3,192 9,372 Apr 03, 2019, 12:00 AM
WRIGHT TIMOTHY MICHAEL Chief R & D Officer Feb 05, 2019 Option Exercise $0.95 40,000 38,000 62,893 Feb 06, 2019, 04:52 PM
Hagan Joseph P President and CEO Feb 05, 2019 Option Exercise $0.95 65,000 61,750 84,148 Feb 06, 2019, 04:51 PM
Chevallard Daniel R. Chief Financial Officer Feb 05, 2019 Option Exercise $0.95 30,000 28,500 34,578 Feb 06, 2019, 04:50 PM
PAPADOPOULOS STELIOS Director Dec 28, 2018 Buy $1.09 50,000 54,570 835,073 Jan 02, 2019, 04:12 PM
PAPADOPOULOS STELIOS Director Dec 27, 2018 Buy $1.04 26,401 27,460 785,073 Dec 28, 2018, 04:21 PM
PAPADOPOULOS STELIOS Director Dec 26, 2018 Buy $0.95 90,000 85,878 758,672 Dec 28, 2018, 04:21 PM
PAPADOPOULOS STELIOS Director Nov 16, 2018 Buy $1.38 300,000 415,470 668,672 Nov 19, 2018, 04:03 PM
PAPADOPOULOS STELIOS Director Nov 15, 2018 Buy $1.33 200,000 265,080 368,672 Nov 19, 2018, 04:03 PM
Collier Kathryn J Director Nov 16, 2018 Buy $1.41 7,100 10,011 27,596 Nov 19, 2018, 04:01 PM
Collier Kathryn J Director Jun 05, 2018 Option Exercise $0.74 7,695 5,694 7,695 Jun 05, 2018, 04:28 PM
Collier Kathryn J Director Apr 14, 2018 Option Exercise $0.64 60,234 38,550 60,234 Apr 17, 2018, 04:36 PM
BALTIMORE DAVID Director Dec 04, 2017 Option Exercise $0.89 60,674 54,000 60,674 Dec 06, 2017, 07:43 PM
FOLETTA MARK G Director Dec 04, 2017 Option Exercise $0.89 71,910 64,000 81,910 Dec 06, 2017, 07:42 PM
PAPADOPOULOS STELIOS Director Dec 04, 2017 Option Exercise $0.89 96,629 86,000 1,797,306 Dec 06, 2017, 07:41 PM
Rosen Hugh Director Dec 04, 2017 Option Exercise $0.89 56,179 49,999 56,179 Dec 06, 2017, 07:40 PM
Witz Pascale Director Dec 04, 2017 Option Exercise $0.89 60,674 54,000 60,674 Dec 06, 2017, 07:39 PM
RASTETTER WILLIAM H Director Dec 04, 2017 Option Exercise $0.89 69,662 61,999 694,387 Dec 06, 2017, 07:38 PM
WRIGHT TIMOTHY MICHAEL Chief R & D Officer Jul 25, 2017 Buy $0.91 274,725 250,000 274,725 Jul 25, 2017, 06:09 PM
RASTETTER WILLIAM H Director Jul 25, 2017 Buy $0.91 274,725 250,000 624,625 Jul 25, 2017, 06:09 PM
Hagan Joseph P President and CEO Jul 25, 2017 Buy $0.91 219,780 200,000 241,297 Jul 25, 2017, 06:08 PM
Chevallard Daniel R. Chief Financial Officer Jul 25, 2017 Buy $0.91 54,945 50,000 59,415 Jul 25, 2017, 06:07 PM
PAPADOPOULOS STELIOS Director Jul 25, 2017 Buy $0.91 1,000,000 910,000 1,770,677 Jul 25, 2017, 06:06 PM
PAPADOPOULOS STELIOS Director Mar 22, 2017 Buy $1.23 300,000 368,100 700,677 Mar 23, 2017, 04:26 PM
PAPADOPOULOS STELIOS Director Mar 21, 2017 Buy $1.20 200,000 239,800 400,677 Mar 23, 2017, 04:26 PM
RASTETTER WILLIAM H Director Mar 07, 2017 Buy $1.15 250,000 287,500 350,000 Mar 07, 2017, 04:59 PM
Hagan Joseph P Chief Operating Officer Mar 03, 2016 Buy $7.19 10,000 71,900 10,000 Mar 07, 2016, 05:20 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Feb 23, 2016 Sale $7.18 1,000,000 7,180,000 4,896,716 Feb 24, 2016, 06:20 PM
FOLETTA MARK G Director Aug 13, 2015 Buy $7.64 10,000 76,405 10,000 Aug 13, 2015, 06:10 PM
PAPADOPOULOS STELIOS Director Aug 07, 2015 Option Exercise $1.55 50,677 78,801 200,677 Aug 07, 2015, 06:05 PM
RASTETTER WILLIAM H Director Jul 21, 2015 Buy $10.19 61,235 624,199 100,000 Jul 21, 2015, 08:47 PM
RASTETTER WILLIAM H Director Jul 20, 2015 Buy $10.13 38,765 392,779 38,765 Jul 21, 2015, 08:47 PM
ISIS PHARMACEUTICALS INC 10% Owner Jul 16, 2015 Sale $10.79 167,000 1,801,362 5,284,172 Jul 17, 2015, 06:08 PM
ISIS PHARMACEUTICALS INC 10% Owner Jul 15, 2015 Sale $10.76 65,133 700,961 5,451,172 Jul 17, 2015, 06:08 PM
ISIS PHARMACEUTICALS INC 10% Owner Jul 17, 2015 Sale $10.21 111,000 1,133,754 5,173,172 Jul 17, 2015, 06:08 PM
ISIS PHARMACEUTICALS INC 10% Owner Jun 30, 2015 Sale $10.79 13,248 143,010 5,516,305 Jul 02, 2015, 04:28 PM
XANTHOPOULOS KLEANTHIS G President and CEO Apr 17, 2015 Option Exercise $0.38 73,929 28,093 77,634 Apr 21, 2015, 07:06 PM
XANTHOPOULOS KLEANTHIS G President and CEO Apr 21, 2015 Option Exercise $0.38 60,000 22,800 63,705 Apr 21, 2015, 07:06 PM
XANTHOPOULOS KLEANTHIS G President and CEO Apr 20, 2015 Option Exercise $0.38 66,071 25,107 69,776 Apr 21, 2015, 07:06 PM
XANTHOPOULOS KLEANTHIS G President and CEO Apr 20, 2015 Sale $16.85 66,071 1,113,514 3,705 Apr 21, 2015, 07:06 PM
XANTHOPOULOS KLEANTHIS G President and CEO Apr 17, 2015 Sale $16.94 73,929 1,252,002 3,705 Apr 21, 2015, 07:06 PM
XANTHOPOULOS KLEANTHIS G President and CEO Apr 21, 2015 Sale $17.73 60,000 1,063,980 3,705 Apr 21, 2015, 07:06 PM
CARTER BRUCE L A Director Apr 13, 2015 Option Exercise $4.78 20,000 95,600 20,000 Apr 14, 2015, 05:12 PM
CARTER BRUCE L A Director Apr 13, 2015 Sale $17.66 20,000 353,164 0 Apr 14, 2015, 05:12 PM
XANTHOPOULOS KLEANTHIS G President and CEO Mar 05, 2015 Option Exercise $0.38 89,230 33,907 91,696 Mar 05, 2015, 07:17 PM
XANTHOPOULOS KLEANTHIS G President and CEO Mar 05, 2015 Sale $20.26 89,230 1,808,063 26,082 Mar 05, 2015, 07:17 PM
XANTHOPOULOS KLEANTHIS G President and CEO Feb 27, 2015 Option Exercise $0.38 70 27 2,536 Mar 03, 2015, 05:27 PM
XANTHOPOULOS KLEANTHIS G President and CEO Feb 27, 2015 Sale $19.50 70 1,365 2,466 Mar 03, 2015, 05:27 PM
XANTHOPOULOS KLEANTHIS G President and CEO Feb 02, 2015 Option Exercise $0.38 2,400 912 4,866 Feb 03, 2015, 05:39 PM
XANTHOPOULOS KLEANTHIS G President and CEO Jan 30, 2015 Option Exercise $0.38 3,300 1,254 5,766 Feb 03, 2015, 05:39 PM
XANTHOPOULOS KLEANTHIS G President and CEO Jan 30, 2015 Sale $19.50 3,300 64,351 2,466 Feb 03, 2015, 05:39 PM
XANTHOPOULOS KLEANTHIS G President and CEO Feb 02, 2015 Sale $19.77 2,400 47,440 2,466 Feb 03, 2015, 05:39 PM
Gibson Neil W Chief Scientific Officer Jan 28, 2015 Sale $18.05 80,000 1,444,304 8,655 Jan 30, 2015, 05:45 PM
XANTHOPOULOS KLEANTHIS G President and CEO Jan 29, 2015 Option Exercise $0.38 60,000 22,800 62,466 Jan 30, 2015, 05:22 PM
XANTHOPOULOS KLEANTHIS G President and CEO Jan 28, 2015 Option Exercise $0.38 85,000 32,300 87,466 Jan 30, 2015, 05:22 PM
XANTHOPOULOS KLEANTHIS G President and CEO Jan 29, 2015 Sale $18.04 60,000 1,082,634 28,693 Jan 30, 2015, 05:22 PM
XANTHOPOULOS KLEANTHIS G President and CEO Jan 28, 2015 Sale $18.08 85,000 1,536,515 15,455 Jan 30, 2015, 05:22 PM
PAPADOPOULOS STELIOS Director Dec 12, 2014 Option Exercise $0.38 150,000 57,000 150,000 Dec 15, 2014, 12:58 PM
Gibson Neil W Chief Scientific Officer Nov 28, 2014 Option Exercise $1.74 2,500 4,350 82,500 Dec 01, 2014, 04:49 PM
Gibson Neil W Chief Scientific Officer Nov 28, 2014 Sale $19.30 2,500 48,245 81,500 Dec 01, 2014, 04:49 PM
ASTRAZENECA PLC 10% Owner Nov 12, 2014 Sale $17.00 2,000,000 34,000,000 4,250,000 Nov 14, 2014, 04:05 PM
ISIS PHARMACEUTICALS INC 10% Owner Nov 03, 2014 Sale $15.94 1,279,411 20,390,613 5,516,305 Nov 05, 2014, 06:48 PM
XANTHOPOULOS KLEANTHIS G President and CEO Oct 29, 2014 Option Exercise $0.38 3,505 1,332 5,971 Oct 31, 2014, 04:52 PM
XANTHOPOULOS KLEANTHIS G President and CEO Oct 29, 2014 Sale $19.35 3,505 67,824 4,571 Oct 31, 2014, 04:52 PM
Gibson Neil W Chief Scientific Officer Oct 29, 2014 Option Exercise $1.74 2,500 4,350 82,500 Oct 31, 2014, 04:50 PM
Gibson Neil W Chief Scientific Officer Oct 29, 2014 Sale $19.29 2,500 48,234 81,400 Oct 31, 2014, 04:50 PM
ISIS PHARMACEUTICALS INC Director Oct 24, 2014 Sale $15.19 1,850 28,109 6,796,512 Oct 28, 2014, 05:03 PM
ISIS PHARMACEUTICALS INC Director Oct 23, 2014 Sale $14.24 1,700 24,202 6,798,066 Oct 28, 2014, 05:03 PM
ISIS PHARMACEUTICALS INC Director Oct 22, 2014 Sale $14.00 109,534 1,533,135 6,899,517 Oct 28, 2014, 05:03 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 24, 2014 Sale $15.19 1,850 28,109 5,897,512 Oct 28, 2014, 04:59 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 23, 2014 Sale $14.24 1,700 24,202 5,899,066 Oct 28, 2014, 04:59 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 22, 2014 Sale $14.00 109,534 1,533,135 6,000,517 Oct 28, 2014, 04:59 PM
ISIS PHARMACEUTICALS INC Director Oct 23, 2014 Sale $14.24 1,700 24,202 6,797,566 Oct 24, 2014, 09:29 PM
ISIS PHARMACEUTICALS INC Director Oct 22, 2014 Sale $14.00 109,534 1,533,126 6,799,266 Oct 24, 2014, 09:29 PM
ISIS PHARMACEUTICALS INC Director Oct 24, 2014 Sale $15.19 1,850 28,109 6,795,716 Oct 24, 2014, 09:29 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 22, 2014 Sale $14.00 109,534 1,533,126 5,900,266 Oct 24, 2014, 09:27 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 24, 2014 Sale $15.19 1,850 28,109 5,896,716 Oct 24, 2014, 09:27 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 23, 2014 Sale $14.24 1,700 24,202 5,898,566 Oct 24, 2014, 09:27 PM
Gibson Neil W Chief Scientific Officer Oct 22, 2014 Option Exercise $1.74 3,300 5,742 83,300 Oct 24, 2014, 04:16 PM
Gibson Neil W Chief Scientific Officer Oct 22, 2014 Sale $14.44 3,300 47,644 80,000 Oct 24, 2014, 04:16 PM
XANTHOPOULOS KLEANTHIS G President and CEO Oct 20, 2014 Option Exercise $0.38 300 114 2,766 Oct 21, 2014, 04:07 PM
XANTHOPOULOS KLEANTHIS G President and CEO Oct 17, 2014 Option Exercise $0.38 400 152 2,866 Oct 21, 2014, 04:07 PM
XANTHOPOULOS KLEANTHIS G President and CEO Oct 17, 2014 Sale $7.04 400 2,816 2,466 Oct 21, 2014, 04:07 PM
XANTHOPOULOS KLEANTHIS G President and CEO Oct 20, 2014 Sale $7.00 300 2,100 2,466 Oct 21, 2014, 04:07 PM
ISIS PHARMACEUTICALS INC Director Oct 16, 2014 Sale $6.76 4,800 32,450 6,911,800 Oct 17, 2014, 05:38 PM
ISIS PHARMACEUTICALS INC Director Oct 15, 2014 Sale $6.67 4,300 28,687 6,916,600 Oct 17, 2014, 05:38 PM
ISIS PHARMACEUTICALS INC Director Oct 17, 2014 Sale $6.79 3,000 20,371 6,908,800 Oct 17, 2014, 05:38 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 16, 2014 Sale $6.76 4,800 32,450 6,012,800 Oct 17, 2014, 05:37 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 15, 2014 Sale $6.67 4,300 28,687 6,017,600 Oct 17, 2014, 05:37 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 17, 2014 Sale $6.79 3,000 20,371 6,009,800 Oct 17, 2014, 05:37 PM
XANTHOPOULOS KLEANTHIS G President and CEO Oct 09, 2014 Option Exercise $0.38 105 40 2,571 Oct 14, 2014, 05:54 PM
XANTHOPOULOS KLEANTHIS G President and CEO Oct 14, 2014 Option Exercise $0.38 400 152 2,866 Oct 14, 2014, 05:54 PM
XANTHOPOULOS KLEANTHIS G President and CEO Oct 09, 2014 Sale $7.00 105 735 2,466 Oct 14, 2014, 05:54 PM
XANTHOPOULOS KLEANTHIS G President and CEO Oct 14, 2014 Sale $7.00 400 2,800 2,466 Oct 14, 2014, 05:54 PM
ISIS PHARMACEUTICALS INC Director Oct 08, 2014 Sale $6.63 3,300 21,888 6,927,650 Oct 10, 2014, 06:26 PM
ISIS PHARMACEUTICALS INC Director Oct 10, 2014 Sale $6.41 2,000 12,813 6,920,900 Oct 10, 2014, 06:26 PM
ISIS PHARMACEUTICALS INC Director Oct 09, 2014 Sale $6.58 4,750 31,238 6,922,900 Oct 10, 2014, 06:26 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 10, 2014 Sale $6.41 2,000 12,813 6,021,900 Oct 10, 2014, 06:25 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 09, 2014 Sale $6.58 4,750 31,238 6,023,900 Oct 10, 2014, 06:25 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 08, 2014 Sale $6.63 3,300 21,888 6,028,650 Oct 10, 2014, 06:25 PM
ISIS PHARMACEUTICALS INC Director Oct 03, 2014 Sale $6.88 3,300 22,688 6,930,950 Oct 03, 2014, 05:20 PM
ISIS PHARMACEUTICALS INC Director Oct 02, 2014 Sale $6.64 3,750 24,903 6,934,250 Oct 03, 2014, 05:20 PM
ISIS PHARMACEUTICALS INC Director Oct 01, 2014 Sale $6.71 3,250 21,808 6,938,000 Oct 03, 2014, 05:20 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 02, 2014 Sale $6.64 3,750 24,903 6,035,250 Oct 03, 2014, 05:19 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 01, 2014 Sale $6.71 3,250 21,808 6,039,000 Oct 03, 2014, 05:19 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Oct 03, 2014 Sale $6.88 3,300 22,688 6,031,950 Oct 03, 2014, 05:19 PM
XANTHOPOULOS KLEANTHIS G President and CEO Sep 30, 2014 Option Exercise $0.38 2,300 874 4,766 Oct 02, 2014, 07:17 PM
XANTHOPOULOS KLEANTHIS G President and CEO Sep 30, 2014 Sale $7.02 2,300 16,137 2,466 Oct 02, 2014, 07:17 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 24, 2014 Sale $7.19 3,750 26,978 6,047,250 Sep 26, 2014, 05:37 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 26, 2014 Sale $7.04 2,500 17,598 6,042,250 Sep 26, 2014, 05:37 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 25, 2014 Sale $7.12 2,500 17,790 6,044,750 Sep 26, 2014, 05:37 PM
ISIS PHARMACEUTICALS INC Director Sep 26, 2014 Sale $7.04 2,500 17,598 6,941,250 Sep 26, 2014, 05:36 PM
ISIS PHARMACEUTICALS INC Director Sep 25, 2014 Sale $7.12 2,500 17,790 6,943,750 Sep 26, 2014, 05:36 PM
ISIS PHARMACEUTICALS INC Director Sep 24, 2014 Sale $7.19 3,750 26,978 6,946,250 Sep 26, 2014, 05:36 PM
ISIS PHARMACEUTICALS INC Director Sep 19, 2014 Sale $7.22 4,100 29,587 6,950,000 Sep 19, 2014, 05:10 PM
ISIS PHARMACEUTICALS INC Director Sep 18, 2014 Sale $7.40 1,500 11,098 6,954,100 Sep 19, 2014, 05:10 PM
ISIS PHARMACEUTICALS INC Director Sep 17, 2014 Sale $7.43 2,100 15,610 6,955,600 Sep 19, 2014, 05:10 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 18, 2014 Sale $7.40 1,500 11,098 6,055,100 Sep 19, 2014, 05:09 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 17, 2014 Sale $7.43 2,100 15,610 6,056,600 Sep 19, 2014, 05:09 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 19, 2014 Sale $7.22 4,100 29,587 6,051,000 Sep 19, 2014, 05:09 PM
Gibson Neil W Chief Scientific Officer Sep 11, 2014 Option Exercise $1.74 2,000 3,480 82,000 Sep 15, 2014, 05:14 PM
Gibson Neil W Chief Scientific Officer Sep 12, 2014 Option Exercise $1.74 2,200 3,828 82,200 Sep 15, 2014, 05:14 PM
Gibson Neil W Chief Scientific Officer Sep 11, 2014 Sale $8.01 2,000 16,010 80,000 Sep 15, 2014, 05:14 PM
Gibson Neil W Chief Scientific Officer Sep 12, 2014 Sale $8.01 2,200 17,616 80,000 Sep 15, 2014, 05:14 PM
ISIS PHARMACEUTICALS INC Director Sep 10, 2014 Sale $7.70 2,000 15,399 6,964,600 Sep 12, 2014, 06:26 PM
ISIS PHARMACEUTICALS INC Director Sep 12, 2014 Sale $7.96 3,500 27,861 6,957,700 Sep 12, 2014, 06:26 PM
ISIS PHARMACEUTICALS INC Director Sep 11, 2014 Sale $7.83 3,400 26,636 6,961,200 Sep 12, 2014, 06:26 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 12, 2014 Sale $7.96 3,500 27,861 6,058,700 Sep 12, 2014, 06:24 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 11, 2014 Sale $7.83 3,400 26,636 6,062,200 Sep 12, 2014, 06:24 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 10, 2014 Sale $7.70 2,000 15,399 6,065,600 Sep 12, 2014, 06:24 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 05, 2014 Sale $7.07 2,400 16,974 6,067,600 Sep 05, 2014, 06:52 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 04, 2014 Sale $7.11 6,000 42,656 6,070,000 Sep 05, 2014, 06:52 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Sep 03, 2014 Sale $6.95 1,650 11,471 6,076,000 Sep 05, 2014, 06:52 PM
ISIS PHARMACEUTICALS INC Director Sep 04, 2014 Sale $7.11 6,000 42,656 6,969,000 Sep 05, 2014, 05:57 PM
ISIS PHARMACEUTICALS INC Director Sep 03, 2014 Sale $6.95 1,650 11,471 6,975,000 Sep 05, 2014, 05:57 PM
ISIS PHARMACEUTICALS INC Director Sep 05, 2014 Sale $7.07 2,400 16,974 6,966,600 Sep 05, 2014, 05:57 PM
ISIS PHARMACEUTICALS INC Director Aug 27, 2014 Sale $7.21 1,500 10,821 6,980,150 Aug 29, 2014, 07:13 PM
ISIS PHARMACEUTICALS INC Director Aug 29, 2014 Sale $6.84 1,500 10,254 6,976,650 Aug 29, 2014, 07:13 PM
ISIS PHARMACEUTICALS INC Director Aug 28, 2014 Sale $6.96 2,000 13,921 6,978,150 Aug 29, 2014, 07:13 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 28, 2014 Sale $6.96 2,000 13,921 6,079,150 Aug 29, 2014, 07:12 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 27, 2014 Sale $7.21 1,500 10,821 6,081,150 Aug 29, 2014, 07:12 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 29, 2014 Sale $6.84 1,500 10,254 6,077,650 Aug 29, 2014, 07:12 PM
XANTHOPOULOS KLEANTHIS G President & CEO Aug 28, 2014 Option Exercise $0.38 3,505 1,332 3,505 Aug 29, 2014, 05:19 PM
XANTHOPOULOS KLEANTHIS G President & CEO Aug 28, 2014 Sale $7.06 3,505 24,754 0 Aug 29, 2014, 05:19 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 22, 2014 Sale $6.75 5,250 35,443 6,082,650 Aug 22, 2014, 07:23 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 21, 2014 Sale $6.89 2,500 17,222 6,087,900 Aug 22, 2014, 07:23 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 20, 2014 Sale $7.14 3,000 21,424 6,090,400 Aug 22, 2014, 07:23 PM
ISIS PHARMACEUTICALS INC Director Aug 20, 2014 Sale $7.14 3,000 21,424 6,989,400 Aug 22, 2014, 07:22 PM
ISIS PHARMACEUTICALS INC Director Aug 22, 2014 Sale $6.75 5,250 35,443 6,981,650 Aug 22, 2014, 07:22 PM
ISIS PHARMACEUTICALS INC Director Aug 21, 2014 Sale $6.89 2,500 17,222 6,986,900 Aug 22, 2014, 07:22 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 14, 2014 Sale $7.04 1,750 12,324 6,094,850 Aug 15, 2014, 07:12 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 13, 2014 Sale $7.02 2,250 15,788 6,096,600 Aug 15, 2014, 07:12 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 15, 2014 Sale $6.98 1,450 10,115 6,093,400 Aug 15, 2014, 07:12 PM
ISIS PHARMACEUTICALS INC Director Aug 15, 2014 Sale $6.98 1,450 10,115 6,992,400 Aug 15, 2014, 07:11 PM
ISIS PHARMACEUTICALS INC Director Aug 14, 2014 Sale $7.04 1,750 12,324 6,993,850 Aug 15, 2014, 07:11 PM
ISIS PHARMACEUTICALS INC Director Aug 13, 2014 Sale $7.02 2,250 15,788 6,995,600 Aug 15, 2014, 07:11 PM
ISIS PHARMACEUTICALS INC Director Aug 06, 2014 Sale $7.08 3,150 22,300 7,002,300 Aug 08, 2014, 08:15 PM
ISIS PHARMACEUTICALS INC Director Aug 08, 2014 Sale $6.80 1,850 12,583 6,997,850 Aug 08, 2014, 08:15 PM
ISIS PHARMACEUTICALS INC Director Aug 07, 2014 Sale $6.66 2,600 17,322 6,999,700 Aug 08, 2014, 08:15 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 08, 2014 Sale $6.80 1,850 12,583 6,098,850 Aug 08, 2014, 08:08 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 07, 2014 Sale $6.66 2,600 17,322 6,100,700 Aug 08, 2014, 08:08 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 06, 2014 Sale $7.08 3,150 22,300 6,103,300 Aug 08, 2014, 08:08 PM
XANTHOPOULOS KLEANTHIS G President & CEO Aug 05, 2014 Option Exercise $0.38 3,505 1,332 3,505 Aug 07, 2014, 05:51 PM
XANTHOPOULOS KLEANTHIS G President & CEO Aug 05, 2014 Sale $7.06 3,505 24,739 0 Aug 07, 2014, 05:51 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Aug 01, 2014 Sale $6.21 2,600 16,153 6,106,450 Aug 01, 2014, 06:52 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 31, 2014 Sale $6.42 1,750 11,235 6,109,050 Aug 01, 2014, 06:52 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 30, 2014 Sale $6.60 1,000 6,602 6,110,800 Aug 01, 2014, 06:52 PM
ISIS PHARMACEUTICALS INC Director Jul 30, 2014 Sale $6.60 1,000 6,602 7,009,800 Aug 01, 2014, 06:44 PM
ISIS PHARMACEUTICALS INC Director Aug 01, 2014 Sale $6.21 2,600 16,153 7,005,450 Aug 01, 2014, 06:44 PM
ISIS PHARMACEUTICALS INC Director Jul 31, 2014 Sale $6.42 1,750 11,235 7,008,050 Aug 01, 2014, 06:44 PM
ISIS PHARMACEUTICALS INC Director Jul 25, 2014 Sale $6.55 1,700 11,137 7,010,800 Jul 25, 2014, 08:41 PM
ISIS PHARMACEUTICALS INC Director Jul 24, 2014 Sale $6.81 1,850 12,598 7,012,500 Jul 25, 2014, 08:41 PM
ISIS PHARMACEUTICALS INC Director Jul 23, 2014 Sale $6.88 1,700 11,702 7,014,350 Jul 25, 2014, 08:41 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 24, 2014 Sale $6.81 1,850 12,598 6,113,500 Jul 25, 2014, 08:40 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 23, 2014 Sale $6.88 1,700 11,702 6,115,350 Jul 25, 2014, 08:40 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 25, 2014 Sale $6.55 1,700 11,137 6,111,800 Jul 25, 2014, 08:40 PM
ISIS PHARMACEUTICALS INC Director Jul 18, 2014 Sale $6.80 5,000 34,001 7,016,050 Jul 18, 2014, 07:19 PM
ISIS PHARMACEUTICALS INC Director Jul 17, 2014 Sale $6.58 5,000 32,906 7,021,050 Jul 18, 2014, 07:19 PM
ISIS PHARMACEUTICALS INC Director Jul 16, 2014 Sale $6.59 3,500 23,058 7,026,050 Jul 18, 2014, 07:19 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 16, 2014 Sale $6.59 3,500 23,058 6,127,050 Jul 18, 2014, 07:17 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 18, 2014 Sale $6.80 5,000 34,001 6,117,050 Jul 18, 2014, 07:17 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 17, 2014 Sale $6.58 5,000 32,906 6,122,050 Jul 18, 2014, 07:17 PM
ISIS PHARMACEUTICALS INC Director Jul 11, 2014 Sale $6.48 1,750 11,339 7,029,550 Jul 11, 2014, 08:25 PM
ISIS PHARMACEUTICALS INC Director Jul 10, 2014 Sale $6.69 4,500 30,109 7,031,300 Jul 11, 2014, 08:25 PM
ISIS PHARMACEUTICALS INC Director Jul 09, 2014 Sale $7.08 1,800 12,748 7,035,800 Jul 11, 2014, 08:25 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 10, 2014 Sale $6.69 4,500 30,109 6,132,300 Jul 11, 2014, 08:25 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 09, 2014 Sale $7.08 1,800 12,748 6,136,800 Jul 11, 2014, 08:25 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 11, 2014 Sale $6.48 1,750 11,339 6,130,550 Jul 11, 2014, 08:25 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 03, 2014 Sale $8.07 1,200 9,678 6,138,600 Jul 07, 2014, 05:19 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jul 02, 2014 Sale $8.07 3,100 25,011 6,139,800 Jul 07, 2014, 05:19 PM
ISIS PHARMACEUTICALS INC 10% Owner Jul 03, 2014 Sale $8.07 1,200 9,678 7,037,600 Jul 07, 2014, 05:14 PM
ISIS PHARMACEUTICALS INC 10% Owner Jul 02, 2014 Sale $8.07 3,100 25,011 7,038,800 Jul 07, 2014, 05:14 PM
Gibson Neil W Chief Scientific Officer Jul 01, 2014 Option Exercise $1.74 2,500 4,350 82,500 Jul 02, 2014, 04:39 PM
Gibson Neil W Chief Scientific Officer Jul 01, 2014 Sale $8.10 2,500 20,260 80,000 Jul 02, 2014, 04:39 PM
XANTHOPOULOS KLEANTHIS G President & CEO Jul 01, 2014 Option Exercise $0.38 3,505 1,332 3,505 Jul 02, 2014, 04:35 PM
XANTHOPOULOS KLEANTHIS G President & CEO Jul 01, 2014 Sale $8.11 3,505 28,426 0 Jul 02, 2014, 04:35 PM
ISIS PHARMACEUTICALS INC 10% Owner Jun 25, 2014 Sale $7.84 2,750 21,566 7,046,750 Jun 27, 2014, 07:00 PM
ISIS PHARMACEUTICALS INC 10% Owner Jun 27, 2014 Sale $7.91 3,150 24,931 7,041,900 Jun 27, 2014, 07:00 PM
ISIS PHARMACEUTICALS INC 10% Owner Jun 26, 2014 Sale $7.89 1,700 13,408 7,045,050 Jun 27, 2014, 07:00 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jun 27, 2014 Sale $7.91 3,150 24,931 6,142,900 Jun 27, 2014, 06:45 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jun 26, 2014 Sale $7.89 1,700 13,408 6,146,050 Jun 27, 2014, 06:45 PM
ALNYLAM PHARMACEUTICALS, INC. 10% Owner Jun 25, 2014 Sale $7.84 2,750 21,566 6,147,750 Jun 27, 2014, 06:45 PM
Gibson Neil W Chief Scientific Officer Jun 17, 2014 Option Exercise $1.74 5,000 8,700 85,000 Jun 18, 2014, 05:54 PM
Gibson Neil W Chief Scientific Officer Jun 17, 2014 Sale $8.05 5,000 40,227 80,000 Jun 18, 2014, 05:54 PM
XANTHOPOULOS KLEANTHIS G President & CEO Jun 09, 2014 Option Exercise $0.38 3,505 1,332 3,505 Jun 09, 2014, 07:31 PM
XANTHOPOULOS KLEANTHIS G President & CEO Jun 09, 2014 Sale $7.14 3,505 25,017 0 Jun 09, 2014, 07:31 PM
XANTHOPOULOS KLEANTHIS G President & CEO May 27, 2014 Option Exercise $0.38 1,743 662 1,743 May 29, 2014, 07:57 PM
XANTHOPOULOS KLEANTHIS G President & CEO May 29, 2014 Option Exercise $0.38 887 337 887 May 29, 2014, 07:57 PM
XANTHOPOULOS KLEANTHIS G President & CEO May 28, 2014 Option Exercise $0.38 875 332 875 May 29, 2014, 07:57 PM
XANTHOPOULOS KLEANTHIS G President & CEO May 27, 2014 Sale $7.00 1,743 12,203 0 May 29, 2014, 07:57 PM
XANTHOPOULOS KLEANTHIS G President & CEO May 29, 2014 Sale $7.00 887 6,209 0 May 29, 2014, 07:57 PM
XANTHOPOULOS KLEANTHIS G President & CEO May 28, 2014 Sale $7.00 875 6,126 0 May 29, 2014, 07:57 PM
Gibson Neil W Chief Scientific Officer Apr 09, 2014 Option Exercise $1.74 2,500 4,350 82,500 Apr 10, 2014, 02:51 PM
Gibson Neil W Chief Scientific Officer Apr 09, 2014 Sale $8.11 2,500 20,271 80,000 Apr 10, 2014, 02:51 PM
XANTHOPOULOS KLEANTHIS G President & CEO Mar 06, 2014 Option Exercise $0.38 3,505 1,332 83,721 Apr 09, 2014, 02:02 PM
XANTHOPOULOS KLEANTHIS G President & CEO Mar 06, 2014 Sale $7.60 3,505 26,623 80,216 Apr 09, 2014, 02:02 PM
XANTHOPOULOS KLEANTHIS G President & CEO Mar 06, 2014 Option Exercise $0.38 3,505 1,332 83,721 Mar 07, 2014, 02:33 PM
XANTHOPOULOS KLEANTHIS G President & CEO Mar 06, 2014 Sale $11.35 3,505 39,778 80,216 Mar 07, 2014, 02:33 PM
Gibson Neil W Chief Scientific Officer Mar 06, 2014 Option Exercise $1.74 2,500 4,350 82,500 Mar 07, 2014, 02:29 PM
Gibson Neil W Chief Scientific Officer Mar 06, 2014 Sale $11.37 2,500 28,428 80,000 Mar 07, 2014, 02:29 PM
XANTHOPOULOS KLEANTHIS G President & CEO Feb 05, 2014 Option Exercise $0.38 3,505 1,332 83,721 Feb 07, 2014, 03:09 PM
XANTHOPOULOS KLEANTHIS G President & CEO Feb 05, 2014 Sale $8.40 3,505 29,437 80,216 Feb 07, 2014, 03:09 PM
Gibson Neil W Chief Scientific Officer Feb 06, 2014 Option Exercise $1.74 45,000 78,300 80,000 Feb 07, 2014, 03:04 PM
Gibson Neil W Chief Scientific Officer Feb 05, 2014 Option Exercise $1.74 2,500 4,350 52,500 Feb 07, 2014, 03:04 PM
Gibson Neil W Chief Scientific Officer Feb 05, 2014 Sale $8.38 17,500 146,706 35,000 Feb 07, 2014, 03:04 PM
Sanofi 10% Owner Feb 04, 2014 Buy $7.67 1,303,780 9,999,993 5,053,779 Feb 05, 2014, 03:38 PM
Gibson Neil W Chief Scientific Officer Jan 21, 2014 Option Exercise $2.66 4,421 11,760 54,421 Jan 23, 2014, 02:33 PM
Gibson Neil W Chief Scientific Officer Jan 21, 2014 Sale $8.09 4,421 35,764 50,000 Jan 23, 2014, 02:33 PM
Gibson Neil W Chief Scientific Officer Jan 17, 2014 Option Exercise $2.17 4,479 9,706 54,479 Jan 21, 2014, 04:03 PM
Gibson Neil W Chief Scientific Officer Jan 17, 2014 Sale $8.15 4,479 36,494 50,000 Jan 21, 2014, 04:03 PM
Gibson Neil W Chief Scientific Officer Jan 16, 2014 Option Exercise $1.74 1,100 1,914 51,100 Jan 17, 2014, 01:35 PM
Gibson Neil W Chief Scientific Officer Jan 16, 2014 Sale $8.03 1,100 8,837 50,000 Jan 17, 2014, 01:35 PM
XANTHOPOULOS KLEANTHIS G President & CEO Jan 02, 2014 Option Exercise $0.38 3,505 1,332 83,721 Jan 02, 2014, 08:52 PM
XANTHOPOULOS KLEANTHIS G President & CEO Jan 02, 2014 Sale $7.25 3,505 25,408 80,216 Jan 02, 2014, 08:52 PM
Gibson Neil W Chief Scientific Officer Feb 04, 2013 Option Exercise $1.74 50,000 87,000 50,000 Feb 14, 2013, 09:08 PM
ISIS PHARMACEUTICALS INC 10% Owner Oct 10, 2012 Buy $4.00 750,000 3,000,000 7,049,500 Oct 11, 2012, 07:56 PM
PARSHALL B LYNNE Director Oct 10, 2012 Buy $4.00 750,000 3,000,000 7,049,500 Oct 11, 2012, 07:53 PM
CROOKE STANLEY T Director Oct 10, 2012 Buy $4.00 750,000 3,000,000 7,049,500 Oct 11, 2012, 07:52 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
PAPADOPOULOS STELIOS Director 11/30/2021 800,000
Aker Christopher Ray Sr. VP & General Counsel 05/17/2021 765
Hagan Joseph P President and CEO 02/16/2021 7,128
Aker Christopher Ray Sr. VP & General Counsel 02/16/2021 1,424
Hagan Joseph P President and CEO 02/16/2021 7,128
PAPADOPOULOS STELIOS Director 12/04/2020 500,002
Walker Paul Edward 10% Owner 12/04/2020 2,735,930
Sonsini Peter W. 10% Owner 12/04/2020 2,735,930
SANDELL SCOTT D 10% Owner 12/04/2020 2,735,930
MAKOWER JOSHUA 10% Owner 12/04/2020 2,735,930
Makhzoumi Mohamad 10% Owner 12/04/2020 2,735,930
Florence Anthony A. Jr. 10% Owner 12/04/2020 2,735,930
Chang Carmen 10% Owner 12/04/2020 2,735,930
Behbahani Ali 10% Owner 12/04/2020 2,735,930
BASKETT FOREST 10% Owner 12/04/2020 2,735,930
Growth Equity Opportunities V, LLC 10% Owner 12/04/2020 2,735,930
Hagan Joseph P President and CEO 12/04/2020 25,002
PAPADOPOULOS STELIOS Director 12/04/2020 500,002
Aker Christopher Ray Sr. VP & General Counsel 11/16/2020 456
Hagan Joseph P President and CEO 11/16/2020 3,176
Hagan Joseph P President and CEO 08/14/2020 2,568
Aker Christopher Ray Sr. VP & General Counsel 08/14/2020 528
Hagan Joseph P President and CEO 05/15/2020 2,774
Aker Christopher Ray Sr. VP & General Counsel 05/15/2020 570
Hagan Joseph P President and CEO 02/18/2020 3,591
Aker Christopher Ray Sr. VP & General Counsel 02/18/2020 737
Hagan Joseph P President and CEO 01/02/2020 8,067
Aker Christopher Ray Sr. VP & General Counsel 01/02/2020 2,164
Aker Christopher Ray Sr. VP & General Counsel 11/14/2019 533
Hagan Joseph P President and CEO 11/14/2019 3,736
Aker Christopher Ray Sr. VP & General Counsel 10/01/2019 1,602
Hagan Joseph P President and CEO 10/01/2019 5,969
Hagan Joseph P President and CEO 08/15/2019 2,409
Aker Christopher Ray Sr. VP & General Counsel 08/15/2019 495
Hagan Joseph P President and CEO 07/01/2019 7,584
Aker Christopher Ray Sr. VP & General Counsel 07/01/2019 2,918
Chevallard Daniel R. Chief Financial Officer 07/01/2019 3,500
PAPADOPOULOS STELIOS Director 05/07/2019 400,000
RASTETTER WILLIAM H Director 05/07/2019 100,320
Witz Pascale Director 05/07/2019 32,000
Hagan Joseph P President and CEO 05/07/2019 35,850
Hagan Joseph P President and CEO 05/16/2019 47,966
Chevallard Daniel R. Chief Financial Officer 05/15/2019 14,089
Aker Christopher Ray Sr. VP & General Counsel 05/15/2019 9,796
Walker Paul Edward 10% Owner 05/07/2019 1,227,640
Walker Paul Edward Director 05/07/2019 1,227,640
Sonsini Peter W. 10% Owner 05/07/2019 1,227,640
SANDELL SCOTT D 10% Owner 05/07/2019 1,227,640
MOTT DAVID M 10% Owner 05/07/2019 1,227,640
MAKOWER JOSHUA 10% Owner 05/07/2019 1,227,640
Makhzoumi Mohamad 10% Owner 05/07/2019 1,227,640
Florence Anthony A. Jr. 10% Owner 05/07/2019 1,227,640
Chang Carmen 10% Owner 05/07/2019 1,227,640
Behbahani Ali 10% Owner 05/07/2019 1,227,640
BASKETT FOREST 10% Owner 05/07/2019 1,227,640
BARRIS PETER J 10% Owner 05/07/2019 1,227,640
Growth Equity Opportunities V, LLC 10% Owner 05/07/2019 1,227,640
Hagan Joseph P President and CEO 05/07/2019 35,850
Witz Pascale Director 05/07/2019 32,000
RASTETTER WILLIAM H Director 05/07/2019 100,320
PAPADOPOULOS STELIOS Director 05/07/2019 400,000
Hagan Joseph P President and CEO 04/01/2019 5,731
Aker Christopher Ray Sr. VP & General Counsel 04/01/2019 2,659
Chevallard Daniel R. Chief Financial Officer 04/01/2019 3,192
WRIGHT TIMOTHY MICHAEL Chief R & D Officer 02/05/2019 38,000
Hagan Joseph P President and CEO 02/05/2019 61,750
Chevallard Daniel R. Chief Financial Officer 02/05/2019 28,500
PAPADOPOULOS STELIOS Director 12/28/2018 54,570
PAPADOPOULOS STELIOS Director 12/27/2018 27,460
PAPADOPOULOS STELIOS Director 12/26/2018 85,878
PAPADOPOULOS STELIOS Director 11/16/2018 415,470
PAPADOPOULOS STELIOS Director 11/15/2018 265,080
Collier Kathryn J Director 11/16/2018 10,011
Collier Kathryn J Director 06/05/2018 5,694
Collier Kathryn J Director 04/14/2018 38,550
BALTIMORE DAVID Director 12/04/2017 54,000
FOLETTA MARK G Director 12/04/2017 64,000
PAPADOPOULOS STELIOS Director 12/04/2017 86,000
Rosen Hugh Director 12/04/2017 49,999
Witz Pascale Director 12/04/2017 54,000
RASTETTER WILLIAM H Director 12/04/2017 61,999
WRIGHT TIMOTHY MICHAEL Chief R & D Officer 07/25/2017 250,000
RASTETTER WILLIAM H Director 07/25/2017 250,000
Hagan Joseph P President and CEO 07/25/2017 200,000
Chevallard Daniel R. Chief Financial Officer 07/25/2017 50,000
PAPADOPOULOS STELIOS Director 07/25/2017 910,000
PAPADOPOULOS STELIOS Director 03/22/2017 368,100
PAPADOPOULOS STELIOS Director 03/21/2017 239,800
RASTETTER WILLIAM H Director 03/07/2017 287,500
Hagan Joseph P Chief Operating Officer 03/03/2016 71,900
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 02/23/2016 7,180,000
FOLETTA MARK G Director 08/13/2015 76,405
PAPADOPOULOS STELIOS Director 08/07/2015 78,801
RASTETTER WILLIAM H Director 07/21/2015 624,199
RASTETTER WILLIAM H Director 07/20/2015 392,779
ISIS PHARMACEUTICALS INC 10% Owner 07/16/2015 1,801,362
ISIS PHARMACEUTICALS INC 10% Owner 07/15/2015 700,961
ISIS PHARMACEUTICALS INC 10% Owner 07/17/2015 1,133,754
ISIS PHARMACEUTICALS INC 10% Owner 06/30/2015 143,010
XANTHOPOULOS KLEANTHIS G President and CEO 04/17/2015 28,093
XANTHOPOULOS KLEANTHIS G President and CEO 04/21/2015 22,800
XANTHOPOULOS KLEANTHIS G President and CEO 04/20/2015 25,107
XANTHOPOULOS KLEANTHIS G President and CEO 04/20/2015 1,113,514
XANTHOPOULOS KLEANTHIS G President and CEO 04/17/2015 1,252,002
XANTHOPOULOS KLEANTHIS G President and CEO 04/21/2015 1,063,980
CARTER BRUCE L A Director 04/13/2015 95,600
CARTER BRUCE L A Director 04/13/2015 353,164
XANTHOPOULOS KLEANTHIS G President and CEO 03/05/2015 33,907
XANTHOPOULOS KLEANTHIS G President and CEO 03/05/2015 1,808,063
XANTHOPOULOS KLEANTHIS G President and CEO 02/27/2015 27
XANTHOPOULOS KLEANTHIS G President and CEO 02/27/2015 1,365
XANTHOPOULOS KLEANTHIS G President and CEO 02/02/2015 912
XANTHOPOULOS KLEANTHIS G President and CEO 01/30/2015 1,254
XANTHOPOULOS KLEANTHIS G President and CEO 01/30/2015 64,351
XANTHOPOULOS KLEANTHIS G President and CEO 02/02/2015 47,440
Gibson Neil W Chief Scientific Officer 01/28/2015 1,444,304
XANTHOPOULOS KLEANTHIS G President and CEO 01/29/2015 22,800
XANTHOPOULOS KLEANTHIS G President and CEO 01/28/2015 32,300
XANTHOPOULOS KLEANTHIS G President and CEO 01/29/2015 1,082,634
XANTHOPOULOS KLEANTHIS G President and CEO 01/28/2015 1,536,515
PAPADOPOULOS STELIOS Director 12/12/2014 57,000
Gibson Neil W Chief Scientific Officer 11/28/2014 4,350
Gibson Neil W Chief Scientific Officer 11/28/2014 48,245
ASTRAZENECA PLC 10% Owner 11/12/2014 34,000,000
ISIS PHARMACEUTICALS INC 10% Owner 11/03/2014 20,390,613
XANTHOPOULOS KLEANTHIS G President and CEO 10/29/2014 1,332
XANTHOPOULOS KLEANTHIS G President and CEO 10/29/2014 67,824
Gibson Neil W Chief Scientific Officer 10/29/2014 4,350
Gibson Neil W Chief Scientific Officer 10/29/2014 48,234
ISIS PHARMACEUTICALS INC Director 10/24/2014 28,109
ISIS PHARMACEUTICALS INC Director 10/23/2014 24,202
ISIS PHARMACEUTICALS INC Director 10/22/2014 1,533,135
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/24/2014 28,109
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/23/2014 24,202
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/22/2014 1,533,135
ISIS PHARMACEUTICALS INC Director 10/23/2014 24,202
ISIS PHARMACEUTICALS INC Director 10/22/2014 1,533,126
ISIS PHARMACEUTICALS INC Director 10/24/2014 28,109
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/22/2014 1,533,126
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/24/2014 28,109
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/23/2014 24,202
Gibson Neil W Chief Scientific Officer 10/22/2014 5,742
Gibson Neil W Chief Scientific Officer 10/22/2014 47,644
XANTHOPOULOS KLEANTHIS G President and CEO 10/20/2014 114
XANTHOPOULOS KLEANTHIS G President and CEO 10/17/2014 152
XANTHOPOULOS KLEANTHIS G President and CEO 10/17/2014 2,816
XANTHOPOULOS KLEANTHIS G President and CEO 10/20/2014 2,100
ISIS PHARMACEUTICALS INC Director 10/16/2014 32,450
ISIS PHARMACEUTICALS INC Director 10/15/2014 28,687
ISIS PHARMACEUTICALS INC Director 10/17/2014 20,371
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/16/2014 32,450
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/15/2014 28,687
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/17/2014 20,371
XANTHOPOULOS KLEANTHIS G President and CEO 10/09/2014 40
XANTHOPOULOS KLEANTHIS G President and CEO 10/14/2014 152
XANTHOPOULOS KLEANTHIS G President and CEO 10/09/2014 735
XANTHOPOULOS KLEANTHIS G President and CEO 10/14/2014 2,800
ISIS PHARMACEUTICALS INC Director 10/08/2014 21,888
ISIS PHARMACEUTICALS INC Director 10/10/2014 12,813
ISIS PHARMACEUTICALS INC Director 10/09/2014 31,238
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/10/2014 12,813
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/09/2014 31,238
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/08/2014 21,888
ISIS PHARMACEUTICALS INC Director 10/03/2014 22,688
ISIS PHARMACEUTICALS INC Director 10/02/2014 24,903
ISIS PHARMACEUTICALS INC Director 10/01/2014 21,808
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/02/2014 24,903
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/01/2014 21,808
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 10/03/2014 22,688
XANTHOPOULOS KLEANTHIS G President and CEO 09/30/2014 874
XANTHOPOULOS KLEANTHIS G President and CEO 09/30/2014 16,137
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/24/2014 26,978
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/26/2014 17,598
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/25/2014 17,790
ISIS PHARMACEUTICALS INC Director 09/26/2014 17,598
ISIS PHARMACEUTICALS INC Director 09/25/2014 17,790
ISIS PHARMACEUTICALS INC Director 09/24/2014 26,978
ISIS PHARMACEUTICALS INC Director 09/19/2014 29,587
ISIS PHARMACEUTICALS INC Director 09/18/2014 11,098
ISIS PHARMACEUTICALS INC Director 09/17/2014 15,610
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/18/2014 11,098
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/17/2014 15,610
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/19/2014 29,587
Gibson Neil W Chief Scientific Officer 09/11/2014 3,480
Gibson Neil W Chief Scientific Officer 09/12/2014 3,828
Gibson Neil W Chief Scientific Officer 09/11/2014 16,010
Gibson Neil W Chief Scientific Officer 09/12/2014 17,616
ISIS PHARMACEUTICALS INC Director 09/10/2014 15,399
ISIS PHARMACEUTICALS INC Director 09/12/2014 27,861
ISIS PHARMACEUTICALS INC Director 09/11/2014 26,636
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/12/2014 27,861
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/11/2014 26,636
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/10/2014 15,399
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/05/2014 16,974
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/04/2014 42,656
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 09/03/2014 11,471
ISIS PHARMACEUTICALS INC Director 09/04/2014 42,656
ISIS PHARMACEUTICALS INC Director 09/03/2014 11,471
ISIS PHARMACEUTICALS INC Director 09/05/2014 16,974
ISIS PHARMACEUTICALS INC Director 08/27/2014 10,821
ISIS PHARMACEUTICALS INC Director 08/29/2014 10,254
ISIS PHARMACEUTICALS INC Director 08/28/2014 13,921
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/28/2014 13,921
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/27/2014 10,821
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/29/2014 10,254
XANTHOPOULOS KLEANTHIS G President & CEO 08/28/2014 1,332
XANTHOPOULOS KLEANTHIS G President & CEO 08/28/2014 24,754
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/22/2014 35,443
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/21/2014 17,222
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/20/2014 21,424
ISIS PHARMACEUTICALS INC Director 08/20/2014 21,424
ISIS PHARMACEUTICALS INC Director 08/22/2014 35,443
ISIS PHARMACEUTICALS INC Director 08/21/2014 17,222
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/14/2014 12,324
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/13/2014 15,788
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/15/2014 10,115
ISIS PHARMACEUTICALS INC Director 08/15/2014 10,115
ISIS PHARMACEUTICALS INC Director 08/14/2014 12,324
ISIS PHARMACEUTICALS INC Director 08/13/2014 15,788
ISIS PHARMACEUTICALS INC Director 08/06/2014 22,300
ISIS PHARMACEUTICALS INC Director 08/08/2014 12,583
ISIS PHARMACEUTICALS INC Director 08/07/2014 17,322
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/08/2014 12,583
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/07/2014 17,322
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/06/2014 22,300
XANTHOPOULOS KLEANTHIS G President & CEO 08/05/2014 1,332
XANTHOPOULOS KLEANTHIS G President & CEO 08/05/2014 24,739
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 08/01/2014 16,153
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/31/2014 11,235
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/30/2014 6,602
ISIS PHARMACEUTICALS INC Director 07/30/2014 6,602
ISIS PHARMACEUTICALS INC Director 08/01/2014 16,153
ISIS PHARMACEUTICALS INC Director 07/31/2014 11,235
ISIS PHARMACEUTICALS INC Director 07/25/2014 11,137
ISIS PHARMACEUTICALS INC Director 07/24/2014 12,598
ISIS PHARMACEUTICALS INC Director 07/23/2014 11,702
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/24/2014 12,598
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/23/2014 11,702
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/25/2014 11,137
ISIS PHARMACEUTICALS INC Director 07/18/2014 34,001
ISIS PHARMACEUTICALS INC Director 07/17/2014 32,906
ISIS PHARMACEUTICALS INC Director 07/16/2014 23,058
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/16/2014 23,058
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/18/2014 34,001
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/17/2014 32,906
ISIS PHARMACEUTICALS INC Director 07/11/2014 11,339
ISIS PHARMACEUTICALS INC Director 07/10/2014 30,109
ISIS PHARMACEUTICALS INC Director 07/09/2014 12,748
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/10/2014 30,109
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/09/2014 12,748
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/11/2014 11,339
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/03/2014 9,678
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 07/02/2014 25,011
ISIS PHARMACEUTICALS INC 10% Owner 07/03/2014 9,678
ISIS PHARMACEUTICALS INC 10% Owner 07/02/2014 25,011
Gibson Neil W Chief Scientific Officer 07/01/2014 4,350
Gibson Neil W Chief Scientific Officer 07/01/2014 20,260
XANTHOPOULOS KLEANTHIS G President & CEO 07/01/2014 1,332
XANTHOPOULOS KLEANTHIS G President & CEO 07/01/2014 28,426
ISIS PHARMACEUTICALS INC 10% Owner 06/25/2014 21,566
ISIS PHARMACEUTICALS INC 10% Owner 06/27/2014 24,931
ISIS PHARMACEUTICALS INC 10% Owner 06/26/2014 13,408
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 06/27/2014 24,931
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 06/26/2014 13,408
ALNYLAM PHARMACEUTICALS, INC. 10% Owner 06/25/2014 21,566
Gibson Neil W Chief Scientific Officer 06/17/2014 8,700
Gibson Neil W Chief Scientific Officer 06/17/2014 40,227
XANTHOPOULOS KLEANTHIS G President & CEO 06/09/2014 1,332
XANTHOPOULOS KLEANTHIS G President & CEO 06/09/2014 25,017
XANTHOPOULOS KLEANTHIS G President & CEO 05/27/2014 662
XANTHOPOULOS KLEANTHIS G President & CEO 05/29/2014 337
XANTHOPOULOS KLEANTHIS G President & CEO 05/28/2014 332
XANTHOPOULOS KLEANTHIS G President & CEO 05/27/2014 12,203
XANTHOPOULOS KLEANTHIS G President & CEO 05/29/2014 6,209
XANTHOPOULOS KLEANTHIS G President & CEO 05/28/2014 6,126
Gibson Neil W Chief Scientific Officer 04/09/2014 4,350
Gibson Neil W Chief Scientific Officer 04/09/2014 20,271
XANTHOPOULOS KLEANTHIS G President & CEO 03/06/2014 1,332
XANTHOPOULOS KLEANTHIS G President & CEO 03/06/2014 26,623
XANTHOPOULOS KLEANTHIS G President & CEO 03/06/2014 1,332
XANTHOPOULOS KLEANTHIS G President & CEO 03/06/2014 39,778
Gibson Neil W Chief Scientific Officer 03/06/2014 4,350
Gibson Neil W Chief Scientific Officer 03/06/2014 28,428
XANTHOPOULOS KLEANTHIS G President & CEO 02/05/2014 1,332
XANTHOPOULOS KLEANTHIS G President & CEO 02/05/2014 29,437
Gibson Neil W Chief Scientific Officer 02/06/2014 78,300
Gibson Neil W Chief Scientific Officer 02/05/2014 4,350
Gibson Neil W Chief Scientific Officer 02/05/2014 146,706
Sanofi 10% Owner 02/04/2014 9,999,993
Gibson Neil W Chief Scientific Officer 01/21/2014 11,760
Gibson Neil W Chief Scientific Officer 01/21/2014 35,764
Gibson Neil W Chief Scientific Officer 01/17/2014 9,706
Gibson Neil W Chief Scientific Officer 01/17/2014 36,494
Gibson Neil W Chief Scientific Officer 01/16/2014 1,914
Gibson Neil W Chief Scientific Officer 01/16/2014 8,837
XANTHOPOULOS KLEANTHIS G President & CEO 01/02/2014 1,332
XANTHOPOULOS KLEANTHIS G President & CEO 01/02/2014 25,408
Gibson Neil W Chief Scientific Officer 02/04/2013 87,000
ISIS PHARMACEUTICALS INC 10% Owner 10/10/2012 3,000,000
PARSHALL B LYNNE Director 10/10/2012 3,000,000
CROOKE STANLEY T Director 10/10/2012 3,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
5.81%
1Q
09/30/2021
03/31/2021
10.20%
2Q
09/30/2021
06/30/2018
-24.58%
13Q
09/30/2021
12/31/2017
4.43%
15Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
5.81%
1Q
03/31/2021
10.20%
2Q
06/30/2018
-24.58%
13Q
12/31/2017
4.43%
15Q
Load More